The SARS-CoV-2 variant BA.3.2 (Cicada) continues to expand its global footprint. As of February 11, 2026, at least 23 countries have reported cases of BA.3.2, with experts warning that the actual circulation may be significantly wider than currently documented. Recent studies indicate that BA.3.2 demonstrates enhanced immune escape capabilities, meaning individuals with prior infection or vaccination using earlier formulations may still be susceptible to reinfection, thereby facilitating greater transmissibility.

Common symptoms associated with BA.3.2 infection include fever or chills, cough, sore throat, nasal congestion, runny nose, fatigue, headache, muscle aches, shortness of breath, loss of taste or smell, nausea, vomiting, and gastrointestinal discomfort. Notably, many patients infected with BA.3.2 have reported experiencing a distinctive “razor blade sore throat” — an intensely painful sensation in the throat resembling the swallowing of blades.

High-risk populations requiring enhanced protection include the elderly , individuals with chronic underlying conditions, cancer patients, immunocompromised persons, pregnant women, infants and young children, and those who have not received updated booster vaccinations. These groups face a higher likelihood of progressing to severe disease upon infection.

The GenSure COVID-19 Antigen Rapid Test Kit has demonstrated robust performance in rapidly detecting the BA.3.2 variant. The test targets the SARS-CoV-2 nucleocapsid (N) protein antigen, which remains highly conserved across circulating variants, including currently monitored Omicron subvariants such as BA.3.2 (Cicada). Laboratory validation studies confirm that the GenSure test maintains high sensitivity when detecting the BA.3.2 strain.

Related GenSure COVID-19 Rapid Testing Products:

· COVID-19 Ag Rapid Test

· COVID-19/Flu A+B Ag Rapid Test

· COVID-19/RSV/Flu A+B Ag Rapid Test

All of the above products are suitable for both professional laboratory use and self-testing.

· COVID-19 IgM Rapid Test

· COVID-19 IgG+IgM Rapid Test

· COVID-19 Antigen Rapid Test Kit

· COVID-19 Neutralizing Antibody Test (Fluorescence)

· COVID-19 Neutralizing Antibody Test (Latex)

· COVID-19/Flu A+B Antigen Combo Rapid Test

· Strep A/COVID-19 Antigen Rapid Test

· Strep A/COVID-19/Flu A+B Antigen Rapid Test

· COVID-19/RSV/Radv/Flu A/B Ag Rapid Test 

· COVID-19/RSV/FluA+B Ag Rapid Test

· COVID-19/RSV/Radv/hMPV/Flu A+B Ag Rapid Test

· COVID-19/Flu A+B/RSV/Radv/hMPV/M.p Ag Rapid Test

· COVID-19/RSV/Radv/M.P/hMPV/hRV/Flu A+B Ag Rapid Test

· COVID-19/Flu A+B/RSV/Radv/hMPV/PIV/hRV Ag Rapid Test

· COVID-19/FluA+B/RSV/Radv/hMPV/M.p/PIV Ag Rapid Test

· COVID-19/FluA+B/RSV+Radv/hMPV+hRV/PIV/M.p Ag Rapid Test

· COVID-19/Flu A+B/M.p Ag Rapid Test

· COVID-19/Flu A+B/RSV/Radv/M.p Ag Rapid Test

· COVID-19/Flu A+B/RSV/hMPV Ag Rapid Test

All of the above products are suitable for professional laboratory use .

Timely testing with the GenSure COVID-19 Antigen Rapid Test Kit enables early identification of infections. Through early detection, prompt isolation, and timely intervention, the risk of virus transmission within households, workplaces, and public settings can be effectively reduced.